Prescription drug · ANDA

Eltrombopag Olamine (eltrombopag) NDC 69238-1414

Eltrombopag olamine 75 mg/1 · Tablet, Film coated · Oral · Amneal Pharmaceuticals NY LLC

NDC codes

FDA NDC Directory
Product NDC (as listed)69238-1414Labeler and product segments. Claims need a package NDC.
Product NDC at billing width69238-1414Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
69238-1414-36923814140330 TABLET, FILM COATED in 1 BOTTLE (69238-1414-3)Marketed from Jan 15, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Eltrombopag Olamine
Generic name (nonproprietary)
eltrombopag
Active ingredients
Eltrombopag olamine — 75 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 212884
Marketing start
Listing expires
Other FDA classes
Breast Cancer Resistance Protein Inhibitors (Mechanism)Increased Megakaryocyte Maturation (Physiologic effect)Increased Platelet Production (Physiologic effect)Organic Anion Transporting Polypeptide 1B1 Inhibitors (Mechanism)Thrombopoietin Receptor Agonists (Mechanism)UGT1A1 Inhibitors (Mechanism)UGT1A3 Inhibitors (Mechanism)UGT1A4 Inhibitors (Mechanism)UGT1A6 Inhibitors (Mechanism)UGT1A9 Inhibitors (Mechanism)UGT2B15 Inhibitors (Mechanism)UGT2B7 Inhibitors (Mechanism)
Identifiers
Product ID 69238-1414_8dba449a-e27a-4f76-a831-6774aa89c217SPL ID 8dba449a-e27a-4f76-a831-6774aa89c217SPL set ID c97337c3-d758-40a3-a1ef-fd122f15e821RxCUI 825421, 825427, 884617, 1245001UNII 4U07F515LGUPC 0369238141634, 0369238141733, 0369238141535, 0369238141436
Pharmacologic class
Thrombopoietin Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238141403 followed by a unit qualifier and the quantity

Package 69238-1414-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Eltrombopag is a thrombopoietin receptor agonist indicated: for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Eltrombopag tablets should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding. ( 1.1 ) for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocyto…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212884

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212884
ProductStrengthForm · routeLabelerProduct NDC
Eltrombopag OlamineeltrombopagEltrombopag olamine 12.5 mg/1Tablet, Film coatedOralAvKARE42291-932
Eltrombopag OlamineeltrombopagEltrombopag olamine 25 mg/1Tablet, Film coatedOralAvKARE42291-933
Eltrombopag OlamineeltrombopagEltrombopag olamine 50 mg/1Tablet, Film coatedOralAvKARE42291-934
Eltrombopag OlamineeltrombopagEltrombopag olamine 75 mg/1Tablet, Film coatedOralAvKARE42291-935
Eltrombopag OlamineeltrombopagEltrombopag olamine 25 mg/1Tablet, Film coatedOralAmneal Pharmaceuticals NY LLC69238-1416
Eltrombopag OlamineeltrombopagEltrombopag olamine 50 mg/1Tablet, Film coatedOralAmneal Pharmaceuticals NY LLC69238-1415
Eltrombopag OlamineeltrombopagEltrombopag olamine 12.5 mg/1Tablet, Film coatedOralAmneal Pharmaceuticals NY LLC69238-1417
Eltrombopag OlamineeltrombopagEltrombopag olamine 12.5 mg/1Tablet, Film coatedOralAmneal Pharmaceuticals NY LLC60219-1417
Eltrombopag OlamineeltrombopagEltrombopag olamine 75 mg/1Tablet, Film coatedOralAmneal Pharmaceuticals NY LLC60219-1414
Eltrombopag OlamineeltrombopagEltrombopag olamine 50 mg/1Tablet, Film coatedOralAmneal Pharmaceuticals NY LLC60219-1415
Eltrombopag OlamineeltrombopagEltrombopag olamine 25 mg/1Tablet, Film coatedOralAmneal Pharmaceuticals NY LLC60219-1416

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Eltrombopag Olamine (eltrombopag) NDC 69238-1414 | Med-Code